new MCQ answer
Published on July 12, 2018, 9:50 a.m.

Sucroferric oxyhydroxide

  • novel iron-based phosphate binders
  • use

  • Hyperphosphatemia

  • to decrease serum phosphorus levels in adult patients with chronic kidney disease  on haemodialysis